| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 12, 2026 | Option exercise(M) | 18K | — | $0 | 49K |
| Aug 12, 2026 | Option exercise(M) | 22K | — | $0 | 70K |
| Aug 12, 2026 | Sell(S) | 9K | $43.64 | $383K | 62K |
| Aug 12, 2026 | Sell(S) | 8K | $43.66 | $361K | 53K |
| Aug 12, 2026 | Sell(S) | 913 | $44.33 | $40K | 52K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 12, 2026 | Option exercise(M) | 18K | — | $0 | 36K |
| Aug 12, 2026 | Option exercise(M) | 22K | — | $0 | 66K |
| Aug 12, 2026 | Grant(A) | 100K | — | $0 | 100K |
| Aug 12, 2026 | Grant(A) | 200K | — | $0 | 200K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001185829-26-000001) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Edgewise Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.